At a conference held earlier this month at the University of Massachusetts Medical School, psychiatrists David Lovas and Zev Schuman-Olivier made the case for and against mindfulness and psychiatric drugs in treating patients with depression, anxiety, schizophrenia, bipolar disorder, and other mental illnesses. Schuman-Olivier is a clinical instructor in psychiatry at Cambridge Health Alliance.
News & Research
